On October 31, 2024, the European Union (EU) began enforcing new import tariffs of up to 45% on electric vehicles (EVs) produced in China. The decision, ratified by EU member states earlier in the month, follows a European Commission investigation which determined that Chinese EV manufacturers receive substantial subsidies.
On January 1, 2025, a revised Combined Nomenclature (CN) will come into effect, as stipulated in Implementing Regulation (EU) 2024/2522 by the European Commission. This update introduces significant changes to commodity codes. Organizations are advised to prepare their processes to avoid delays and errors in customs declarations.
The European Parliament has approved a one-year postponement for companies to comply with the EU’s deforestation regulation. This decision responds to concerns from businesses, member states, and international partners about the feasibility of meeting the original deadlines.
Starting in 2025, the NVWA will implement several important tariff changes. These include higher fees due to the integration of KDS and new charges for specific activities, such as TSE sampling and occupational health assessments in slaughterhouses.
On October 2, the European Commission proposed a 12-month delay in implementing the EU Deforestation Regulation (EUDR), with new start dates of December 30, 2025, for large companies and June 30, 2026, for SMEs.
The European Commission has taken another critical step towards the implementation of the EU Deforestation Regulation (EUDR) by proposing an additional 12-month phasing-in period. This
In December 2022, the Regulation establishing the European Union Single Window Environment for Customs came into force (Regulation (EU) 2022/2399). This regulation aims to simplify the processing of information related to non-customs formalities.
The European Commission has adopted a package of infringement decisions due to Member States failing to communicate measures taken to transpose EU directives into national law.
As of 1 July 2024, significant changes have been implemented regarding the declaration of pharmaceutical products (medicines) and active substances for import.
These cheap goods are currently subject to a customs exemption, meaning that no import duties are due when entering the EU. The European commission is now planning to remove this exemption.
